News

2026.02.12
Genomtec lines up technology trials with potential Asian partners during M&A efforts

2025.07.31
Genomtec's Supervisory Board appointed Leroy Huntley to the Company's Management Board

2025.07.14
Genomtec has the consent of its shareholders to make a contribution of assets to its subsidiaries in order to accelerate the project sale process

2025.03.26
Genomtec implements changes in organizational structure to accelerate M&A process

2025.03.12
The company will obtain approximately PLN 11 million from the issue to support the commercialization of projects

Archive

2023.09.28

Genomtec S.A. expands its Genomtec ID platform to oncology and has filed a patent application specific to oncology diagnostics

Genomtec has successfully completed the expansion of its Genomtec ID platform in the field of oncological diagnostics and has filed a patent ...
Read
2023.07.07

The M&A process runs in parallel with research and development activities

– We are concentrating our efforts on multiple areas that are directly linked to the Genomtec ID platform. Our main focus lies in ...
Read
2023.05.30

Genomtec at BIO International Convention

We are pleased to announce that Genomtec team (Miron Tokarski & Charudutt Shah) will attend BIO 2023 from Jun 5-8, 2023 in Boston. ...
Read
2023.05.12

Interview with Miron Tokarski, CEO of Genomtec S.A. at Gazeta Giełdy i Inwestorów „Parkiet”

Key interview subjects: – Funds raised from the share issue will impact the realization of milestones and increase the value of ...
Read
2023.04.27

Genomtec S.A. will raise PLN 13.1 million from share issue

Funds will increase the value of the Company’s technology in M&A transaction. More informtaion: ...
Read
2023.03.29

Presentation – Genomtec’s development plans and the status of the M&A process

We invite you to watch the webinar and chat with Genomtec’s Management Board, which took place on Strefa Inwestorów on Wednesday, March 29. ...
Read

Archive